Toll/interleukin-1 receptor (TIR) domain-containing proteins have NAD-RNA decapping activity

Nat Commun. 2024 Mar 13;15(1):2261. doi: 10.1038/s41467-024-46499-y.

Abstract

The occurrence of NAD+ as a non-canonical RNA cap has been demonstrated in diverse organisms. TIR domain-containing proteins present in all kingdoms of life act in defense responses and can have NADase activity that hydrolyzes NAD+. Here, we show that TIR domain-containing proteins from several bacterial and one archaeal species can remove the NAM moiety from NAD-capped RNAs (NAD-RNAs). We demonstrate that the deNAMing activity of AbTir (from Acinetobacter baumannii) on NAD-RNA specifically produces a cyclic ADPR-RNA, which can be further decapped in vitro by known decapping enzymes. Heterologous expression of the wild-type but not a catalytic mutant AbTir in E. coli suppressed cell propagation and reduced the levels of NAD-RNAs from a subset of genes before cellular NAD+ levels are impacted. Collectively, the in vitro and in vivo analyses demonstrate that TIR domain-containing proteins can function as a deNAMing enzyme of NAD-RNAs, raising the possibility of TIR domain proteins acting in gene expression regulation.

MeSH terms

  • Bacteria / genetics
  • Escherichia coli* / genetics
  • Escherichia coli* / metabolism
  • NAD* / metabolism
  • RNA Caps / metabolism
  • Receptors, Interleukin-1

Substances

  • NAD
  • RNA Caps
  • Receptors, Interleukin-1